Nivolumab for Resected Stage III or IV Melanoma at 9 YearsPaolo A. Ascierto, James Larkin, Ana Arance et al.|New England Journal of Medicine|2025Cited by 21
1089P Adjuvant nivolumab (NIVO) vs ipilimumab (IPI) in resected stage III/IV melanoma: 7-y results from CheckMate 238Paolo A. Ascierto, James Larkin, Michele Del Vecchio et al.|Annals of Oncology|2023Cited by 9